Serdar Deger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Serdar Deger has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
J. Roigas
Department of Urology, Charité Campus Mitte, Charité University Medicine Berlin, Germany
5 shared publicationsDirk Boehmer
4 shared publicationsJan Roigas
4 shared publicationsVolker Budach
4 shared publications- Carsten Stephan
Department of Urology, Charité—Universitätsmedizin Berlin, 10117 Berlin, Germany
3 shared publications - Michael Lein
Department of Urology, Charité – Universitätsmedizin Berlin, Berlin, Germany
3 shared publications
Latest Publications
- Open Access
- 1 July 2011
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 57 (7) , 995-1004
Between-Method Differences in Prostate-Specific Antigen Assays Affect Prostate Cancer Risk Prediction by Nomograms
BACKGROUND To date, no published nomogram for prostate cancer (PCa) risk prediction has considered the between-method differences associated with estimating concentrations of prostate-specific antigen (PSA). METHODS Total PSA (tPSA) and free PSA were measured in 780 biopsy-referred men with 5 different assays. These data, together with other clinical parameters, were applied to 5 published nomograms that are used for PCa detection. Discrimination and calibration criteria were used to characterize the accuracy of the nomogram models under these conditions. RESULTS PCa was found in 455 men (58.3%), and 325 men had no evidence of malignancy. Median tPSA concentrations ranged from 5.5 μg/L to 7.04 μg/L, whereas the median percentage of free PSA ranged from 10.6% to 16.4%. Both the calibration and discrimination of the nomograms varied significantly across different types of PSA assays. Median PCa probabilities, which indicate PCa risk, ranged from 0.59 to 0.76 when different PSA assays were used within the same nomogram. On the other hand, various nomograms produced different PCa probabilities when the same PSA assay was used. Although the ROC curves had comparable areas under the ROC curve, considerable differences were observed among the 5 assays when the sensitivities and specificities at various PCa probability cutoffs were analyzed. CONCLUSIONS The accuracy of the PCa probabilities predicted according to different nomograms is limited by the lack of agreement between the different PSA assays. This difference between methods may lead to unacceptable variation in PCa risk prediction. A more cautious application of nomograms is recommended.
- 1 July 2011
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 57 (7) , 995-1004
Open AccessBetween-Method Differences in Prostate-Specific Antigen Assays Affect Prostate Cancer Risk Prediction by Nomograms
BACKGROUND To date, no published nomogram for prostate cancer (PCa) risk prediction has considered the between-method differences associated with estimating concentrations of prostate-specific antigen (PSA). METHODS Total PSA (tPSA) and free PSA were measured in 780 biopsy-referred men with 5 different assays. These data, together with other clinical parameters, were applied to 5 published nomograms that are used for PCa detection. Discrimination and calibration criteria were used to characterize the accuracy of the nomogram models under these conditions. RESULTS PCa was found in 455 men (58.3%), and 325 men had no evidence of malignancy. Median tPSA concentrations ranged from 5.5 μg/L to 7.04 μg/L, whereas the median percentage of free PSA ranged from 10.6% to 16.4%. Both the calibration and discrimination of the nomograms varied significantly across different types of PSA assays. Median PCa probabilities, which indicate PCa risk, ranged from 0.59 to 0.76 when different PSA assays were used within the same nomogram. On the other hand, various nomograms produced different PCa probabilities when the same PSA assay was used. Although the ROC curves had comparable areas under the ROC curve, considerable differences were observed among the 5 assays when the sensitivities and specificities at various PCa probability cutoffs were analyzed. CONCLUSIONS The accuracy of the PCa probabilities predicted according to different nomograms is limited by the lack of agreement between the different PSA assays. This difference between methods may lead to unacceptable variation in PCa risk prediction. A more cautious application of nomograms is recommended.
- 1 July 2009
- Vol. 29 (7) , 2589-600
New markers and multivariate models for prostate cancer detection.
Specificity of PSA has been enhanced by using molecular forms of PSA and free PSA (fPSA) such as percent free PSA (% fPSA), proPSA, intact PSA or BPHA and/or new serum markers. Most of these promising new serum markers like EPCA2 or ANXA3 still lack confirmation of outstanding initial results or show only marginal enhanced specificity at high sensitivity levels. PCA3, TMPRSS2-ERG, and other analytes in urine collected after digital rectal examination with application of mild digital pressure have potential to preferentially detect aggressive PCa and to decrease the rate of unnecessary repeat biopsies. The combination of these new urinary markers with new and established serum markers seems to be most promising to further increase specificity of tPSA. Multivariate models e.g. artificial neural networks (ANN) or logistic regression (LR)-based nomograms have been recently developed by incorporating these new markers in several studies. There is generally an advantage to including new markers and clinical data as additional parameters to PSA and % fPSA within ANN and LR models. The results and unexpected pitfalls of these studies are shown.
- 1 July 2009
- Vol. 29 (7) , 2589-600
New markers and multivariate models for prostate cancer detection.
Specificity of PSA has been enhanced by using molecular forms of PSA and free PSA (fPSA) such as percent free PSA (% fPSA), proPSA, intact PSA or BPHA and/or new serum markers. Most of these promising new serum markers like EPCA2 or ANXA3 still lack confirmation of outstanding initial results or show only marginal enhanced specificity at high sensitivity levels. PCA3, TMPRSS2-ERG, and other analytes in urine collected after digital rectal examination with application of mild digital pressure have potential to preferentially detect aggressive PCa and to decrease the rate of unnecessary repeat biopsies. The combination of these new urinary markers with new and established serum markers seems to be most promising to further increase specificity of tPSA. Multivariate models e.g. artificial neural networks (ANN) or logistic regression (LR)-based nomograms have been recently developed by incorporating these new markers in several studies. There is generally an advantage to including new markers and clinical data as additional parameters to PSA and % fPSA within ANN and LR models. The results and unexpected pitfalls of these studies are shown.
- 28 January 2009
- Published by Georg Thieme Verlag KG in Aktuelle Urologie
- Vol. 40 (01) , 23-26
Neue Entwicklungen in der minimalinvasiven Urologie: NOTES (Natural Orifice Transluminal Endoscopic Surgery) und LESS (Laparoendoscopic Single-Site Surgery) in der Urologie
In der Urologie haben laparoskopische Operationen innerhalb der letzten Dekade eine rasante Entwicklung genommen. In mehreren Studien konnten die Vorteile der Laparoskopie belegt werden. Die neuesten Innovationen im Bereich der minimalinvasiven Urologie haben das Ziel, die operativen Zugänge zu verkleinern und damit die Morbidität weiter zu verringern. Mit dieser Zielstellung zeichnen sich gegenwärtig zwei Entwicklungen ab. Natural Orifice Transluminal Endoscopic Surgery (NOTES), die natürliche Körperöffnungen nutzt und Laparo-Endoscopic Single-Site Surgery (LESS), wo sowie über einen Zugang mehrere Instrumente eingeführt als auch Präparate geborgen werden. Die Einführung von NOTES und / oder LESS kann als eine weitere Entwicklung der minimalinvasiven Eingriffe in der Urologie betrachtet werden. In den letzten zwei Jahren wurden eine Vielzahl von Fallberichten und kleinen Patientenserien zu diesem Thema publiziert. Randomisierte Studien hinsichtlich der potenziellen Vorteile wie Patientenmorbidität, Rekonvaleszenz und Schmerzmittelverbrauch gegenüber der konventionellen Laparoskopie oder offenen Chirurgie existieren derzeit nicht. Es scheint, dass LESS in der urologischen Gemeinschaft in Vergleich zu NOTES mehr Anklang gefunden hat. Die Möglichkeit der Adaptation der konventionellen Laparoskopie, der ähnlichen Arbeitsabläufe scheinen dabei die Hauptgründe zu sein. NOTES und LESS sind neue innovative Techniken, für die Machbarkeitsstudien nicht nur bei urologischen Routineeingriffen, wie die einfache Nephrektomie, sondern auch bei anspruchsvolleren rekonstruktiven Eingriffen, wie die partielle Nephrektomie, die radikale Prostatektomie oder die Ureterozystoneostomie innerhalb der letzten zwei Jahren durchgeführt worden sind. In den nächsten Jahren können weitere Vergleichsstudien zwischen dieser Techniken und der konventionellen Laparoskopie erwartet werden. Laparoscopic surgery in urology has undergone a rapid development in the last decade. In general, many studies have underlined the benefits of laparoscopy in urology. The latest innovations in the field of minimally invasive urology are aimed at a further reduction of the morbidity associated with minimally invasive surgery. Two novel innovations are currently being developed, natural orifice transluminal endoscopic surgery (NOTES), whereby intraperitoneal access is gained through natural orifices and laparo-endoscopic single-site surgery (LESS), wherein one surgical access is used both for introducing instruments and for retrieving the specimen. Many case reports and small patient series have been published rapidly in the past two years. However, comparative randomised studies to conventional laparoscopy or open surgery do not yet exist. LESS and NOTES are two new innovative approaches, whereby feasibility studies not only for simple nephrectomy but also for complex procedures like partial nephrectomy, radical prostatectomy, ureterocystoneostomy have been published. In the next few years, comparative studies between these techniques and conventional laparascopy can be expected.
- 28 January 2009
- Published by Georg Thieme Verlag KG in Aktuelle Urologie
- Vol. 40 (01) , 23-26
Neue Entwicklungen in der minimalinvasiven Urologie: NOTES (Natural Orifice Transluminal Endoscopic Surgery) und LESS (Laparoendoscopic Single-Site Surgery) in der Urologie
In der Urologie haben laparoskopische Operationen innerhalb der letzten Dekade eine rasante Entwicklung genommen. In mehreren Studien konnten die Vorteile der Laparoskopie belegt werden. Die neuesten Innovationen im Bereich der minimalinvasiven Urologie haben das Ziel, die operativen Zugänge zu verkleinern und damit die Morbidität weiter zu verringern. Mit dieser Zielstellung zeichnen sich gegenwärtig zwei Entwicklungen ab. Natural Orifice Transluminal Endoscopic Surgery (NOTES), die natürliche Körperöffnungen nutzt und Laparo-Endoscopic Single-Site Surgery (LESS), wo sowie über einen Zugang mehrere Instrumente eingeführt als auch Präparate geborgen werden. Die Einführung von NOTES und / oder LESS kann als eine weitere Entwicklung der minimalinvasiven Eingriffe in der Urologie betrachtet werden. In den letzten zwei Jahren wurden eine Vielzahl von Fallberichten und kleinen Patientenserien zu diesem Thema publiziert. Randomisierte Studien hinsichtlich der potenziellen Vorteile wie Patientenmorbidität, Rekonvaleszenz und Schmerzmittelverbrauch gegenüber der konventionellen Laparoskopie oder offenen Chirurgie existieren derzeit nicht. Es scheint, dass LESS in der urologischen Gemeinschaft in Vergleich zu NOTES mehr Anklang gefunden hat. Die Möglichkeit der Adaptation der konventionellen Laparoskopie, der ähnlichen Arbeitsabläufe scheinen dabei die Hauptgründe zu sein. NOTES und LESS sind neue innovative Techniken, für die Machbarkeitsstudien nicht nur bei urologischen Routineeingriffen, wie die einfache Nephrektomie, sondern auch bei anspruchsvolleren rekonstruktiven Eingriffen, wie die partielle Nephrektomie, die radikale Prostatektomie oder die Ureterozystoneostomie innerhalb der letzten zwei Jahren durchgeführt worden sind. In den nächsten Jahren können weitere Vergleichsstudien zwischen dieser Techniken und der konventionellen Laparoskopie erwartet werden. Laparoscopic surgery in urology has undergone a rapid development in the last decade. In general, many studies have underlined the benefits of laparoscopy in urology. The latest innovations in the field of minimally invasive urology are aimed at a further reduction of the morbidity associated with minimally invasive surgery. Two novel innovations are currently being developed, natural orifice transluminal endoscopic surgery (NOTES), whereby intraperitoneal access is gained through natural orifices and laparo-endoscopic single-site surgery (LESS), wherein one surgical access is used both for introducing instruments and for retrieving the specimen. Many case reports and small patient series have been published rapidly in the past two years. However, comparative randomised studies to conventional laparoscopy or open surgery do not yet exist. LESS and NOTES are two new innovative approaches, whereby feasibility studies not only for simple nephrectomy but also for complex procedures like partial nephrectomy, radical prostatectomy, ureterocystoneostomy have been published. In the next few years, comparative studies between these techniques and conventional laparascopy can be expected.
- 25 January 2008
- Vol. 27, 4315-20
Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies.
THE AIM of this study was to determine the prostate cancer detection rate of targeted biopsy using contrast-enhanced ultrasound (US) in patients with elevated prostate specific antigen (PSA) levels and previous negative biopsy. A total of 114 patients initially underwent ultrasonography using transrectal ultrasound (TRUS) and power Doppler. All the patients had at least one previous biopsy series negative for prostate carcinoma. Ninety-five of the patients were examined with a new broadband Doppler technique, advanced dynamic flow (ADF), after i.v. injection of the echo enhancer (2.4 ml, SonoVue). The systematic biopsies were also obtained supplemented by removal of two targeted tissue cores in all the patients with a suspicious area in the inflow phase or late phase. Histology confirmed prostate cancer in 30 of the 95 patients. Sensitivity for the detection of prostate cancer by contrast-enhanced US was 100% and specificity was 48%. Suspicious areas were identified in 48 cases including 40 hypervascularized areas and 14 hypoechoic areas after 60 sec. Targeted biopsy identified 24 of the 30 carcinomas. Randomized octant biopsy identified only 8 of the 30 carcinomas. All 65 patients with negative histology were prostate cancer free at 12-month follow-up. The ADF US scans were degraded by fewer artifacts than the power Doppler images. Contrast-enhanced ADF Doppler allows reliable differentiation of prostate cancer and normal prostate tissue with a high sensitivity in patients with previous negative biopsy and fewer artifacts than power Doppler images, thus providing a good basis for targeted prostate biopsy instead of systematic biopsy.
- 25 January 2008
- Vol. 27, 4315-20
Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies.
THE AIM of this study was to determine the prostate cancer detection rate of targeted biopsy using contrast-enhanced ultrasound (US) in patients with elevated prostate specific antigen (PSA) levels and previous negative biopsy. A total of 114 patients initially underwent ultrasonography using transrectal ultrasound (TRUS) and power Doppler. All the patients had at least one previous biopsy series negative for prostate carcinoma. Ninety-five of the patients were examined with a new broadband Doppler technique, advanced dynamic flow (ADF), after i.v. injection of the echo enhancer (2.4 ml, SonoVue). The systematic biopsies were also obtained supplemented by removal of two targeted tissue cores in all the patients with a suspicious area in the inflow phase or late phase. Histology confirmed prostate cancer in 30 of the 95 patients. Sensitivity for the detection of prostate cancer by contrast-enhanced US was 100% and specificity was 48%. Suspicious areas were identified in 48 cases including 40 hypervascularized areas and 14 hypoechoic areas after 60 sec. Targeted biopsy identified 24 of the 30 carcinomas. Randomized octant biopsy identified only 8 of the 30 carcinomas. All 65 patients with negative histology were prostate cancer free at 12-month follow-up. The ADF US scans were degraded by fewer artifacts than the power Doppler images. Contrast-enhanced ADF Doppler allows reliable differentiation of prostate cancer and normal prostate tissue with a high sensitivity in patients with previous negative biopsy and fewer artifacts than power Doppler images, thus providing a good basis for targeted prostate biopsy instead of systematic biopsy.
- 31 October 2007
- Published by Elsevier in European Urology
- Vol. 52 (4) , 1269-1270
Re: Renaud Bollens, Dimitri Mikhaski, Baldo P. Espinoza, Alberto Rosenblatt, Anh Dung Hoang, Daniel Abramowicz, Vincent Donckier and Claude Schulman. Laparoscopic Live Donor Right Nephrectomy: A New Technique to Maximize the Length of the Renal Vein Using a Modified Endo GIA Stapler? Eur Urol 2007;51:1326–31
- 31 October 2007
- Published by Elsevier in European Urology
- Vol. 52 (4) , 1269-1270
Re: Renaud Bollens, Dimitri Mikhaski, Baldo P. Espinoza, Alberto Rosenblatt, Anh Dung Hoang, Daniel Abramowicz, Vincent Donckier and Claude Schulman. Laparoscopic Live Donor Right Nephrectomy: A New Technique to Maximize the Length of the Renal Vein Using a Modified Endo GIA Stapler? Eur Urol 2007;51:1326–31
- 1 April 2005
- Published by Elsevier in European Urology
- Vol. 47 (4) , 441-448
High Dose Rate (HDR) Brachytherapy with Conformal Radiation Therapy for Localized Prostate Cancer
- 1 April 2005
- Published by Elsevier in European Urology
- Vol. 47 (4) , 441-448
High Dose Rate (HDR) Brachytherapy with Conformal Radiation Therapy for Localized Prostate Cancer
- 1 April 2005
- Published by Taylor & Francis in Minimally Invasive Therapy & Allied Technologies
- Vol. 14 (2) , 57-61
Laparoscopic donor nephrectomy
Laparoscopic live donor nephrectomy (LDN) has removed disincentives of potential donors and may bear the potential to increase kidney donation. Multiple modifications have been made to abbreviate the learning curve while at the same time guarantee the highest possible level of medical quality for donor and recipient. We reviewed the literature for the evolution of the different LDN techniques and their impact on donor, graft and operating surgeon, including the subtleties of different surgical accesses, vessel handling and organ extraction. We performed a literature search (PubMed, DIMDI, medline) to evaluate the development of the LDN techniques from 1995 to 2003. Today more than 200 centres worldwide perform LDN. Hand‐assistance has led to a spread of LDN. Studies comparing open and hand‐assisted LDN show a reduction of operating and warm ischaemia times for the hand‐assisted LDN. Different surgical access sites (trans‐ or retroperitoneal), different vessel dissection approaches, donor organ delivery techniques, delivery sites and variations of hand‐assistance techniques reflect the evolution of LDN. Proper techniques and their combination for the consecutive surgical steps minimize both warm ischaemia time and operating time while offering the donor a safe minimally invasive laparoscopic procedure. LDN has breathed new life into the moribund field of living kidney donation. Within a few years LDN could become the standard approach in living kidney donation. Surgeons working in this field must be trained thoroughly and well acquainted with the subtleties of the different LDN techniques and their respective advantages and disadvantages.
- 1 April 2005
- Published by Taylor & Francis in Minimally Invasive Therapy & Allied Technologies
- Vol. 14 (2) , 57-61
Laparoscopic donor nephrectomy
Laparoscopic live donor nephrectomy (LDN) has removed disincentives of potential donors and may bear the potential to increase kidney donation. Multiple modifications have been made to abbreviate the learning curve while at the same time guarantee the highest possible level of medical quality for donor and recipient. We reviewed the literature for the evolution of the different LDN techniques and their impact on donor, graft and operating surgeon, including the subtleties of different surgical accesses, vessel handling and organ extraction. We performed a literature search (PubMed, DIMDI, medline) to evaluate the development of the LDN techniques from 1995 to 2003. Today more than 200 centres worldwide perform LDN. Hand‐assistance has led to a spread of LDN. Studies comparing open and hand‐assisted LDN show a reduction of operating and warm ischaemia times for the hand‐assisted LDN. Different surgical access sites (trans‐ or retroperitoneal), different vessel dissection approaches, donor organ delivery techniques, delivery sites and variations of hand‐assistance techniques reflect the evolution of LDN. Proper techniques and their combination for the consecutive surgical steps minimize both warm ischaemia time and operating time while offering the donor a safe minimally invasive laparoscopic procedure. LDN has breathed new life into the moribund field of living kidney donation. Within a few years LDN could become the standard approach in living kidney donation. Surgeons working in this field must be trained thoroughly and well acquainted with the subtleties of the different LDN techniques and their respective advantages and disadvantages.
- 1 May 2004
- Published by Elsevier in European Urology
- Vol. 45 (5) , 574-580
Thermoradiotherapy Using Interstitial Self-Regulating Thermoseeds: An Intermediate Analysis of a Phase II Trial
- 1 May 2004
- Published by Elsevier in European Urology
- Vol. 45 (5) , 574-580
Thermoradiotherapy Using Interstitial Self-Regulating Thermoseeds: An Intermediate Analysis of a Phase II Trial
- 1 January 2004
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 38 (3) , 263-265
Laparoscopic anatrophic nephrolithotomy
Management of staghorn calculi is still a challenge. To combine the surgical principles of treatment with the minimal invasive access we performed a laparoscopic anatrophic nephrolithotomy in a female patient successfully. Patient was discharged free of stone on fifth postoperative day. No complications occurred.
- 1 January 2004
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 38 (3) , 263-265
Laparoscopic anatrophic nephrolithotomy
Management of staghorn calculi is still a challenge. To combine the surgical principles of treatment with the minimal invasive access we performed a laparoscopic anatrophic nephrolithotomy in a female patient successfully. Patient was discharged free of stone on fifth postoperative day. No complications occurred.
- 30 January 2003
- Published by Springer Nature in Der Urologe
- Vol. 42 (3) , 347-353
Die laparoskopische Nierenbeckenplastik mit Kontinuitätstrennung nach Anderson-Hynes
Because of the minimal invasiveness of the laparoscopic approach, we introduced the laparoscopic dismembered pyeloplasty in our treatment modalities for patients with primary UPJ obstruction. We report on our technique and the results after a median follow-up of more than 2 years. Between August 1997 and September 2002, 52 patients underwent a laparoscopic dismembered pyeloplasty at our institution. All patients had a symptomatic primary PJ obstruction. We prefer the transperitoneal route with laterocolic exposure of the kidney. After preparation and exposure of the ureter and the renal pelvis, we performed in each case the dismembered Anderson-Hynes pyeloplasty with resection of the pelvis and reanastomosis between the ureter and renal pelvis. Intracorporeal suturing and knotting techniques were used exclusively. All procedures could be performed successfully. In no case was conversion to open surgery necessary. The mean operative time was 180 min. Crossing vessels were present in 57% of patients. The mean postoperative hospital stay was 4 days. The first patient had an anastomosis insufficiency, which required laparoscopic repair. The same patient failed in the follow-up. He developed a late recurrence of the stenosis and needed an open repair. In all other patients the obstruction was resolved or significantly improved. The long-term success rate is 98% with a follow-up of 25 months. Our results with laparoscopic dismembered pyeloplasties compare favorably with those achieved by open pyeloplasties with less perioperative morbidity and discomfort. We do believe that laparoscopic dismembered pyeloplasty will be the method of choice in the treatment of UPJ obstruction.
- 30 January 2003
- Published by Springer Nature in Der Urologe
- Vol. 42 (3) , 347-353
Die laparoskopische Nierenbeckenplastik mit Kontinuitätstrennung nach Anderson-Hynes
Because of the minimal invasiveness of the laparoscopic approach, we introduced the laparoscopic dismembered pyeloplasty in our treatment modalities for patients with primary UPJ obstruction. We report on our technique and the results after a median follow-up of more than 2 years. Between August 1997 and September 2002, 52 patients underwent a laparoscopic dismembered pyeloplasty at our institution. All patients had a symptomatic primary PJ obstruction. We prefer the transperitoneal route with laterocolic exposure of the kidney. After preparation and exposure of the ureter and the renal pelvis, we performed in each case the dismembered Anderson-Hynes pyeloplasty with resection of the pelvis and reanastomosis between the ureter and renal pelvis. Intracorporeal suturing and knotting techniques were used exclusively. All procedures could be performed successfully. In no case was conversion to open surgery necessary. The mean operative time was 180 min. Crossing vessels were present in 57% of patients. The mean postoperative hospital stay was 4 days. The first patient had an anastomosis insufficiency, which required laparoscopic repair. The same patient failed in the follow-up. He developed a late recurrence of the stenosis and needed an open repair. In all other patients the obstruction was resolved or significantly improved. The long-term success rate is 98% with a follow-up of 25 months. Our results with laparoscopic dismembered pyeloplasties compare favorably with those achieved by open pyeloplasties with less perioperative morbidity and discomfort. We do believe that laparoscopic dismembered pyeloplasty will be the method of choice in the treatment of UPJ obstruction.